Skip to main content

Q - ARCH CAPITAL GROUP LTD.

For the period ended Jun 30, 2025. Filed Aug 5, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 5, 2025

ACGL$109.14+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Item 1. Consolidated Financial Statements

Page No.
Consolidated Balance Sheets
June 30, 2025 and December 31, 2024 (unaudited)5
Consolidated Statements of Income
For the three and six month periods ended June 30, 2025 and 2024 (unaudited)6
Consolidated Statements of Comprehensive Income
For the three and six month periods ended June 30, 2025 and 2024 (unaudited)7
Consolidated Statements of Changes in Shareholders’ Equity
For the three and six month periods ended June 30, 2025 and 2024 (unaudited)8
Consolidated Statements of Cash Flows
For the six month periods ended June 30, 2025 and 2024 (unaudited)9
Notes to Consolidated Financial Statements (unaudited)
Note 1 - Basis of Presentation and Recent Accounting Pronouncements10
Note 2 - Acquisitions10
Note 3 - Share Transactions11
Note 4 - Earnings Per Common Share12
Note 5 - Segment Information13
Note 6 - Reserve for Losses and Loss Adjustment Expenses18
Note 7 - Allowance for Expected Credit Losses20
Note 8 - Investment Information22
Note 9 - Fair Value28
Note 10 - Derivative Instruments34
Note 11 - Commitments and Contingencies35
Note 12 - Variable Interest Entities35
Note 13 - Other Comprehensive Income (Loss)36
Note 14 - Income Taxes37
Note 15 - Legal Proceedings37
Note 16 - Transactions with Related Parties37
Note 17 - Subsequent Event37
ARCH CAPITAL42025 SECOND QUARTER FORM 10-Q
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.